The microwave stimulated immunodetection of a tumor associated antigen (TAG-12) by monoclonal antibody 7A9 and an avidinbiotinylated alkaline phosphatase kit was compared with the conventional staining method. No difference in the staining pattern of antibody 7A9 was noticed in serial paraffin sections of 50 specimens including normal, benign and malignant breast tissues after microwave irradiated and conventional immunostaining. The results demonstrate that microwave stimulated immunostaining gives reliable results and can remarkably reduce the time of the staining procedure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/10520299109110554 | DOI Listing |
Cancer Immunol Immunother
December 2024
Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Virchows Arch
December 2024
Department of Pathology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif cedex, France.
The double inactivation of TP53 and RB1 is considered typical of neuroendocrine carcinomas (NECs) but is assumed to be rare in high-grade neuroendocrine tumors (NETs). The immunohistochemical determination of the p53 and Rb status has therefore been proposed as a diagnostic tool. We studied this status in a large series of high-grade neuroendocrine neoplasms, from multiple origins, in order to (a) assess the patterns observed in the different histopathological categories, (b) compare them between the various anatomic sites, and (c) evaluate their possible diagnostic relevance.
View Article and Find Full Text PDFMol Vis
November 2024
Department of Ophthalmology and Visual Science, Federal University of São Paulo, São Paulo, Brazil, UNIFESP.
BMC Cancer
October 2024
Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France.
J Med Chem
October 2024
Laboratory of Laser Molecular Spectroscopy, Department of Chemistry, Institute of Applied Radiation Chemistry, Lodz University of Technology, Wroblewskiego 15, 93-590Lodz, Poland.
Conventional assays such as immunohistochemistry (IHC) and hybridization (ISH) used in clinical procedures for quantification of the human epidermal growth factor receptor-2 (HER2) status in breast cancer have many limitations. In the current study, we have used HER2 expression in a broad range of breast cancer phenotypes to explore the potential utility of a novel immunodetection technique using Raman spectroscopy and Raman imaging combined with artificial intelligence models. The correlations between the Raman method and conventional HER2 testing methodologies (IHC and ISH) have been tested.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!